+944.8%
MRNA vs KTOS
-55.0%
+999.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | KTOS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.3% | +5.1% | +0.2% | +4.3% |
| 7D | +14.6% | -14.6% | +29.2% | +17.6% |
| 30D | +29.4% | -16.3% | +45.7% | +33.3% |
| 3M | +371.9% | -38.9% | +410.8% | +418.7% |
| 6M | +421.0% | -42.9% | +463.9% | +474.3% |
| YTD | +762.0% | -53.8% | +815.7% | +791.8% |
| 1Y | +944.8% | -51.5% | +996.3% | +949.4% |
| All | +944.8% | -55.0% | +999.7% | +949.4% |
Cumulative growth
Daily Returns
Daily percentage return beside KTOS.
Daily Out/Under-Performance
Portfolio return minus KTOS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × KTOS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded KTOS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling